MedTrace Logo

Fungal Infections in Patients With Hematological Malignancies

NCT03650439 · Status: UNKNOWN · Type: OBSERVATIONAL · Enrollment: 50

Last updated 2018-08-28

No results posted yet for this study

Summary

\* Report the prevalence of fungal infections among patients with hematological malignancies in South Egypt Cancer Institute. \* Detect the most endemic fungal pathogen isolated from patients with hematological malignancies in South Egypt Cancer Institute. \*Antifungal susceptibility testing which guide the optimal approach to treat fungal infections. \* detection of resistant gene expression by real time PCR. \* Fungal genome sequencing analysis to determine the genetic back ground upon which mutation and resistance occur.

Conditions

Interventions

DIAGNOSTIC_TEST

culture on Sabouraud's Dextrose Agar (SDA)

• Clinical samples will be cultured onto Sabouraud's Dextrose Agar (SDA) plates supplemented with chloramphenicol. the culture was incubated at 25 C° and at 37° C (for yeasts and moulds isolation )

Sponsors & Collaborators

  • Assiut University

    lead OTHER

Eligibility

Min Age
18 Years
Max Age
75 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2018-10-01
Primary Completion
2019-09-30
Completion
2019-10-31

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT03650439 on ClinicalTrials.gov